A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Danaher Corp stock. As of the latest transaction made, Citadel Advisors LLC holds 1,078,900 shares of DHR stock, worth $251 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
1,078,900
Previous 786,600 37.16%
Holding current value
$251 Million
Previous $197 Million 52.61%
% of portfolio
0.06%
Previous 0.04%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$239.25 - $280.76 $160 Million - $188 Million
670,160 Added 54662.32%
671,386 $187 Million
Q2 2024

Aug 14, 2024

SELL
$235.51 - $267.98 $5.84 Million - $6.65 Million
-24,808 Reduced 95.29%
1,226 $306,000
Q1 2024

May 15, 2024

SELL
$224.58 - $256.19 $10.6 Million - $12.1 Million
-47,305 Reduced 64.5%
26,034 $6.5 Million
Q4 2023

Feb 14, 2024

SELL
$185.1 - $233.13 $240 Million - $302 Million
-1,297,500 Reduced 94.65%
73,339 $17 Million
Q3 2023

Nov 14, 2023

BUY
$233.08 - $265.59 $181 Million - $206 Million
775,503 Added 130.26%
1,370,839 $340 Million
Q2 2023

Aug 14, 2023

BUY
$224.99 - $256.14 $9.66 Million - $11 Million
42,940 Added 7.77%
595,336 $143 Million
Q1 2023

May 15, 2023

BUY
$239.75 - $277.0 $61.2 Million - $70.7 Million
255,111 Added 85.81%
552,396 $139 Million
Q4 2022

Feb 14, 2023

SELL
$241.42 - $282.29 $87.9 Million - $103 Million
-364,069 Reduced 55.05%
297,285 $78.9 Million
Q3 2022

Nov 14, 2022

BUY
$247.06 - $1507.4 $142 Million - $865 Million
573,907 Added 656.29%
661,354 $171 Million
Q2 2022

Aug 15, 2022

SELL
$237.11 - $299.66 $227 Million - $287 Million
-958,741 Reduced 91.64%
87,447 $22.2 Million
Q1 2022

May 16, 2022

SELL
$257.27 - $315.76 $67.8 Million - $83.2 Million
-263,547 Reduced 20.12%
1,046,188 $307 Million
Q4 2021

Feb 14, 2022

BUY
$292.08 - $329.01 $92.1 Million - $104 Million
315,277 Added 31.7%
1,309,735 $431 Million
Q3 2021

Nov 15, 2021

BUY
$272.21 - $332.43 $96.7 Million - $118 Million
355,375 Added 55.61%
994,458 $303 Million
Q2 2021

Aug 16, 2021

SELL
$225.08 - $271.69 $208 Million - $251 Million
-923,609 Reduced 59.1%
639,083 $172 Million
Q1 2021

May 17, 2021

BUY
$212.38 - $245.9 $47.1 Million - $54.5 Million
221,808 Added 16.54%
1,562,692 $352 Million
Q4 2020

Feb 16, 2021

BUY
$212.5 - $245.46 $79 Million - $91.3 Million
371,927 Added 38.38%
1,340,884 $298 Million
Q3 2020

Nov 16, 2020

SELL
$177.16 - $215.33 $66 Million - $80.2 Million
-372,649 Reduced 27.78%
968,957 $209 Million
Q2 2020

Aug 14, 2020

SELL
$128.7 - $176.83 $82.7 Million - $114 Million
-642,647 Reduced 32.39%
1,341,606 $237 Million
Q1 2020

May 15, 2020

BUY
$121.39 - $169.05 $237 Million - $330 Million
1,954,168 Added 6495.49%
1,984,253 $275 Million
Q4 2019

Feb 14, 2020

BUY
$133.47 - $153.48 $3.12 Million - $3.59 Million
23,359 Added 347.29%
30,085 $4.62 Million
Q3 2019

Nov 14, 2019

BUY
$135.4 - $146.47 $388,733 - $420,515
2,871 Added 74.47%
6,726 $971,000
Q2 2019

Aug 14, 2019

SELL
$124.88 - $143.73 $42.5 Million - $49 Million
-340,671 Reduced 98.88%
3,855 $551,000
Q1 2019

May 15, 2019

SELL
$97.62 - $132.29 $47 Million - $63.7 Million
-481,441 Reduced 58.29%
344,526 $0
Q4 2018

Feb 14, 2019

BUY
$94.85 - $109.54 $72.6 Million - $83.9 Million
765,694 Added 1270.38%
825,967 $85.2 Million
Q3 2018

Nov 13, 2018

SELL
$98.13 - $108.9 $30.2 Million - $33.5 Million
-307,626 Reduced 83.62%
60,273 $0
Q2 2018

Aug 10, 2018

SELL
$96.1 - $103.24 $108 Million - $116 Million
-1,123,820 Reduced 75.34%
367,899 $0
Q1 2018

May 11, 2018

BUY
$92.16 - $103.8 $105 Million - $119 Million
1,142,467 Added 327.12%
1,491,719 $146 Million
Q4 2017

Feb 09, 2018

SELL
$85.26 - $94.62 $154 Million - $171 Million
-1,805,669 Reduced 83.79%
349,252 $32.4 Million
Q3 2017

Nov 09, 2017

BUY
$79.29 - $88.45 $171 Million - $191 Million
2,154,921
2,154,921 $185 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $170B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.